Filing Details

Accession Number:
0001144204-13-044095
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-08 19:01:05
Reporting Period:
2013-08-06
Filing Date:
2013-08-08
Accepted Time:
2013-08-08 19:01:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509420 D Chandra Lovejoy 3000 Kent Ave Ste A1-100
West Lafayette IN 47906
Vp Of Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-06 6,130 $3.05 6,130 No 4 M Direct
Common Stock Acquisiton 2013-08-06 215 $2.54 6,345 No 4 M Direct
Common Stock Acquisiton 2013-08-06 655 $2.54 7,000 No 4 M Direct
Common Stock Disposition 2013-08-06 7,000 $17.29 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-08-06 6,130 $0.00 6,130 $3.05
Common Stock Stock Option (right to buy) Disposition 2013-08-06 215 $0.00 215 $2.54
Common Stock Stock Option (right to buy) Disposition 2013-08-06 655 $0.00 655 $2.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
479 2017-11-14 No 4 M Direct
0 2019-03-05 No 4 M Direct
0 2019-08-13 No 4 M Direct
Footnotes
  1. Shares subject to the option vested 50% on November 14, 2009 and monthly over a period of 24 months beginning on November 30, 2009.
  2. Shares subject to the option vested monthly over a period of 48 months beginning on March 31, 2009.
  3. Shares subject to the option vested monthly over a period of 48 months beginning on August 31, 2009.
  4. Represents the sale of 7,000 shares in multiple transactions, ranging in price from $17.2701 to $17.35 per share, resulting in a weighted average sale price per share of $17.29. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.